<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335614">
  <stage>Registered</stage>
  <submitdate>15/06/2010</submitdate>
  <approvaldate>8/07/2010</approvaldate>
  <actrnumber>ACTRN12610000551099</actrnumber>
  <trial_identification>
    <studytitle>Minimally invasive hip replacement for osteoarthritis of the hip - a randomised trial</studytitle>
    <scientifictitle>A comparative study of minimally invasive total hip replacement for osteoarthritis, with emphasis on complications and clinical scores</scientifictitle>
    <utrn>U1111-1115-5024</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Osteoarthritis of the hip</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Single-incision mini-posterior approach to the hip. This technique involves a smaller incision (around 10cm) and sparing of some short external rotators (namely Piriformis) than a standard approach. Each approach takes the same time (around 60-90 minutes)</interventions>
    <comparator>Standard posterior approach to the hip. This approach involves a generous incision (around 20cm), and detachment of all short external rotator muscles. Each approach takes the same time (around 60-90 minutes)</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Complication rate from surgery, including fractures, infection and dislocation. These will be assessed clinically and by xray</outcome>
      <timepoint>2 weeks, 6 weeks, 3 months, 1 year and 2 years post-operation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Clinical scores (function): Oxford Hip Score, 6-minute walk test</outcome>
      <timepoint>3 months, 1 year and 2 years post-operation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Satisfaction: Visual analogue scale</outcome>
      <timepoint>3 months, 1 year and 2 years post-operation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The impact on the muscle of cutting the tendon (in the standard group) using the preserved tendon (in the less invasive group) as a control. This outcome is assessed using magnetic resonance imaging (MRI) of the Piriformis and Obturator Internus in a subgroup of 20 patients.</outcome>
      <timepoint>Preoperative, and 3 months and 2 years postoperative.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Primary osteoarthritis (OA) of the hip</inclusivecriteria>
    <inclusiveminage>70</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Previous surgery to the hip
Trauma to the hip
Dysplasia</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Enrolled through outpatient clinic. Allocation concealment using central randomisation by computer</concealment>
    <sequence>Simple randomisation by using a randomization table created by a computer software (i.e., computerised sequence generation)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/08/2005</anticipatedstartdate>
    <actualstartdate>1/09/2005</actualstartdate>
    <anticipatedenddate />
    <actualenddate>3/11/2007</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Riaz Khan</primarysponsorname>
    <primarysponsoraddress>Suite 1, Hollywood Medical Centre, 85 Monash Ave, Nedlands, WA 6009, Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>There has been a recent drive to perform hip replacements through smaller incisions. The question is, does this increase the risk of complications? The primary purpose was to assess whether a hip replaced through a smaller incision produced as good a result as when done through a standard incision. Our hypothesis was that it did, and was possibly more beneficial since fewer tissues were divided.</summary>
    <trialwebsite />
    <publication>A comparison of a less invasive Piriformis-sparing approach versus the standard posterior approach to the hip. 
Khan RJK, Maor D, Hofmann M and Haebich S.
JBJS Br 2012; 94B (1): 43-50</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sir Charles Gairdner Group Human research Ethics Committee</ethicname>
      <ethicaddress>Level 2,  A Block, Hospital Ave, Nedlands, WA 6009</ethicaddress>
      <ethicapprovaldate>15/10/2004</ethicapprovaldate>
      <hrec>2008 - 158</hrec>
      <ethicsubmitdate>5/02/2004</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Riaz Khan</name>
      <address>Suite 1, Hollywood Medical Centre, 85 Monash Ave, Nedlands, 6009, WA</address>
      <phone>+61 8 93863933</phone>
      <fax>+61 8 93863015</fax>
      <email>rjkkhan@gmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Riaz Khan</name>
      <address>Suite 1, Hollywood Medical Centre, 85 Monash Ave, Nedlands, 6009, WA</address>
      <phone>+61 8 93863933</phone>
      <fax>+61 8 93863015</fax>
      <email>rjkkhan@gmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Riaz Khan</name>
      <address>Ste 1
Hollywood Medical Centre
85 Monash Ave
Nedlands
WA 6009</address>
      <phone>+61 8 93863933</phone>
      <fax>+61 8 93863015</fax>
      <email>rjkkhan@gmail.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Riaz Khan</name>
      <address>The Joint Studio, 85 Monash Ave, Nedlands, WA 6009 </address>
      <phone>+61 8 93863933   </phone>
      <fax />
      <email>rjkkhan@gmail.com </email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>